Upcoming NIDDK R01: engineering stem cell-derived islet cells to improve diabetes cell replacement therapies
NIDDK plans a future R01 funding opportunity to support research that engineers stem cell-derived islet cell products to improve durability and function of diabetes cell-replacement therapies. It will encourage preclinical studies and collaborations across stem cell/islet biology, transplant immunology, and type 1 diabetes autoimmunity. This is a notice of intent; applications are not being ac…
The National Institute of Diabetes and Digestive and Kidney Diseases intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research on understanding how to engineer inherent characteristics of stem cell-derived islet cell products that can result in improved…
Funding Source
Awards & funding
Eligibility
Indian/Native American Tribal Governments (Other than Federally Recognized)Eligible Agencies of the Federal GovernmentU.S. Territory or PossessionFaith-based or Community-based OrganizationsRegional OrganizationsNon-domestic (non-U.S.) Entities (Foreign Institutions)
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers